Cardiac Urea Cycle Activation by Time-Restricted Feeding Protects Against Pressure Overload-Induced Heart Failure

被引:0
|
作者
Tan, Yanzhen [1 ,2 ]
Li, Min [1 ]
Li, Han [1 ]
Guo, Yongzheng [3 ]
Zhang, Bing [2 ]
Wu, Guiling [1 ]
Li, Jia [1 ]
Zhang, Qian [1 ]
Sun, Yang [4 ]
Gao, Feng [1 ]
Yi, Wei [2 ]
Zhang, Xing [1 ,5 ]
机构
[1] Fourth Mil Med Univ, Sch Aerosp Med, Minist Educ, Key Lab, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Div Cardiol, Cardiovasc Dis Lab, Chongqing 400016, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Peoples R China
[5] Air Force Med Ctr, Dept Rehabil, Beijing 100142, Peoples R China
基金
中国国家自然科学基金;
关键词
amino acid utilization; heart failure; time-restricted feeding; urea cycle; AMINO-ACID CATABOLISM; CARDIOMETABOLIC HEALTH; METABOLISM; WEIGHT; PLASMA; RISK;
D O I
10.1002/advs.202407677
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Heart failure is a leading cause of mortality worldwide, necessitating the development of novel therapeutic and lifestyle interventions. Recent studies highlight a potential role of time-restricted feeding (TRF) in the prevention and treatment of cardiac diseases. Here, it is found that TRF protected against heart failure at different stages in mice. Metabolomic profiling revealed that TRF upregulated most circulating amino acids, and amino acid supplementation protected against heart failure. In contrast, TRF showed a mild effect on cardiac amino acid profile, but increased cardiac amino acid utilization and activated the cardiac urea cycle through upregulating argininosuccinate lyase (ASL) expression. Cardiac-specific ASL knockout abolished the cardioprotective effects afforded by TRF. Circulating amino acids also protected against heart failure through activation of the urea cycle. Additionally, TRF upregulated cardiac ASL expression through transcription factor Yin Yang 1, and urea cycle-derived NO contributes to TRF-afforded cardioprotection. Furthermore, arteriovenous gradients of circulating metabolites across the human hearts were measured, and found that amino acid utilization and urea cycle activity were impaired in patients with decreased cardiac function. These results suggest that TRF is a promising intervention for heart failure, and highlight the importance of urea cycle in regulation of cardiac function.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Activation of Cardiac Fibulin-4 Protects Against Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
    van Deel, Elza
    van Vliet, Nicole
    van den Bosch, Thierry
    van Spreeuwel, Ariane
    Bax, Noortje
    Boontje, Nicky
    Sasaki, Takako
    Van der Velden, Jolanda
    Bouten, C.
    von der Thusen, Jan
    Danser, Jan H.
    Duncker, Dirk J.
    Van der Pluijm, Ingrid
    Essers, Jeroen
    CIRCULATION, 2022, 146
  • [2] Triptolide protects rat heart against pressure overload-induced cardiac fibrosis and inflammation activation
    Zhang, Zhengang
    Ni, Yue
    Zhang, Kai
    Qin, Jianhua
    Sun, Hongguang
    Ding, Yongling
    Zhao, Pei
    Xing, Dongqi
    Gong, Kaizheng
    FASEB JOURNAL, 2011, 25
  • [3] Triptolide protects rat heart against pressure overload-induced cardiac fibrosis
    Zhang, Zhengang
    Qu, Xinkai
    Ni, Yue
    Zhang, Kai
    Dong, Zhifeng
    Yan, Xiaochen
    Qin, Jianhua
    Sun, Hongguang
    Ding, Yongling
    Zhao, Pei
    Gong, Kaizheng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2498 - 2505
  • [4] Shensongyangxin protects against pressure overload-induced cardiac hypertrophy
    Shen, Di-Fei
    Wu, Qing-Qing
    Ni, Jian
    Deng, Wei
    Wei, Cong
    Jia, Zhen-Hua
    Zhou, Heng
    Zhou, Meng-Qiao
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    MOLECULAR MEDICINE REPORTS, 2016, 13 (01) : 980 - 988
  • [5] LACK OF ADIPOSE TISSUE LIPOLYSIS PROTECTS AGAINST PRESSURE OVERLOAD-INDUCED HEART FAILURE
    Foryst-Ludwig, A.
    Salatzki, J.
    Brix, S.
    Ban, Z.
    Grune, J.
    Klopfleisch, R.
    Rothe, M.
    Kershaw, E.
    Kintscher, U.
    ATHEROSCLEROSIS, 2016, 252 : E259 - E259
  • [6] Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis
    Li, Jun
    Li, Liudong
    Chu, Hongxia
    Sun, Xiaojian
    Ge, Zhiming
    PHARMACEUTICAL BIOLOGY, 2014, 52 (08) : 1045 - 1051
  • [7] Signal transducer and transcriptional activation 1 protects against pressure overload-induced cardiac hypertrophy
    Zhen, Changlin
    Liu, Hongxia
    Gao, Li
    Tong, Yuanyuan
    He, Chaoyong
    FASEB JOURNAL, 2021, 35 (01):
  • [8] Shen'ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure
    Qiu, Boyong
    Qiao, Siyu
    Shi, Xiujuan
    Shen, Lin
    Deng, Bing
    Ma, Zilin
    Zhou, Duan
    Wei, Yihong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1875 - 1890
  • [9] Tongxinluo Protects against Pressure Overload-Induced Heart Failure in Mice Involving VEGF/Akt/eNOS Pathway Activation
    Wang, Bo
    Yang, Qing
    Bai, Wen-wu
    Xing, Yi-fan
    Lu, Xiao-ting
    Sun, Yuan-yuan
    Zhao, Yu-xia
    PLOS ONE, 2014, 9 (06):
  • [10] Absence of microRNA-155 protects against pressure overload-induced cardiac inflammation and failure
    Schroen, Blanche
    Corsten, Maarten
    Janssen, Ben J.
    Creemers, Esther E.
    Pinto, Yigal M.
    Zacchigna, Serena
    Giacca, Mauro
    Vigorito, Elena
    Thum, Thomas
    Carmeliet, Peter
    Mayr, Manuel
    de Windt, Leon
    Lutgens, Esther
    de Winther, Menno
    Papageorgiou, Anna
    Heymans, Stephane
    FASEB JOURNAL, 2012, 26